{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:13:38Z","timestamp":1776287618718,"version":"3.50.1"},"reference-count":14,"publisher":"Oncology Nursing Society (ONS)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1188\/18.cjon.199-202","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T17:06:56Z","timestamp":1521220016000},"page":"199-202","source":"Crossref","is-referenced-by-count":15,"title":["Heparin Versus Normal Saline: Flushing Effectiveness in Managing Central Venous Catheters in Patients Undergoing Blood and Marrow Transplantation"],"prefix":"10.1188","volume":"22","author":[{"given":"John","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Jepsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Reich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2018,4,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aimoto, M., Yamane, T., Shiomoto, K., Sakamoto, C., Nakashima, Y., Koh, H., . . . Miyata, S. (2013). Refractoriness to platelet transfusion in acute myeloid leukemia correlated with the optical density of anti-platelet factor 4\/heparin antibodies. International Journal of Hematology, 98, 472\u2013477. https:\/\/doi.org\/10.1007\/s12185-013-1427-4","DOI":"10.1007\/s12185-013-1427-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bertoglio, S., Solari, N., Meszaros, P., Vassallo, F., Bonvento, M., Pastorino, S., & Bruzzi, P. (2012). Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nursing, 35, E35\u2013E42. https:\/\/doi.org\/10.1097\/NCC.0b013e31823312b1","DOI":"10.1097\/NCC.0b013e31823312b1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Dal Molin, A., Allara, E., Montani, D., Milani, S., Frassati, C., Cossu, S., . . . Rasero, L. (2014). Flushing the central venous catheter: Is heparin necessary? Journal of Vascular Access, 15, 241\u2013248. https:\/\/doi.org\/10.5301\/jva.5000225","DOI":"10.5301\/jva.5000225"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Goossens, G.A., J\u00e9r\u00f4me, M., Janssens, C., Peetermans, W.E., Fieuws, S., Moons, P., . . . Stas, M. (2013). Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: A randomised, non-inferiority, open trial. Annals of Oncology, 24, 1892\u20131899. https:\/\/doi.org\/10.1093\/annonc\/mdt114","DOI":"10.1093\/annonc\/mdt114"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Heidari Gorji, M.A., Rezaei, F., Jafari, H., & Yazdani Cherati, J. (2015). Comparison of the effects of heparin and 0.9% sodium chloride solutions in maintenance of patency of central venous catheters. Anesthesiology and Pain Medicine, 5(2), e22595. https:\/\/doi.org\/10.5812\/aapm.22595","DOI":"10.5812\/aapm.22595"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Jonker, M.A., Osterby, K.R., Vermeulen, L.C., Kleppin, S.M., & Kudsk, K.A. (2010). Does low-dose heparin maintain central venous access device patency?: A comparison of heparin versus saline during a period of heparin shortage. Journal of Parenteral and Enteral Nutrition, 34, 444\u2013449. https:\/\/doi.org\/10.1177\/0148607110362082","DOI":"10.1177\/0148607110362082"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Julious, S.A. (2005). Sample size of 12 per group rule of thumb for a pilot study. Pharmaceutical Statistics, 4, 287\u2013291. https:\/\/doi.org\/10.1002\/pst.185","DOI":"10.1002\/pst.185"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Keeler, M. (2014). Central line practice in Canadian blood and marrow transplant. Canadian Oncolology Nursing Journal, 24, 67\u201377.","DOI":"10.5737\/1181912x2426771"},{"key":"9","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Briz, E., Ruiz Garcia, V., Cabello, J.B., Bort-Marti, S., Carbonell Sanchis, R., & Burls, A. (2014). Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews, 10, CD008462. https:\/\/doi.org\/10.1002\/14651858.CD008462.pub2","DOI":"10.1002\/14651858.CD008462.pub2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Mayo, D.J., Cullinane, A.M., Merryman, P.K., & Horne, M.K., III. (1999). Serologic evidence of heparin sensitization in cancer patients receiving heparin flushes of venous access devices. Supportive Care in Cancer, 7, 425\u2013427.","DOI":"10.1007\/s005200050303"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Mitchell, M.D., Anderson, B.J., Williams, K., & Umscheid, C.A. (2009). Heparin flushing and other interventions to maintain patency of central venous catheters: A systematic review. Journal of Advanced Nursing, 65, 2007\u20132021.","DOI":"10.1111\/j.1365-2648.2009.05103.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"O\u2019Grady, N.P., Alexander, M., Burns, L.A., Dellinger, E.P., Garland, J., Heard, S.O., . . . Saint, S. (2011). Guidelines for the prevention of intravascular catheter-related infections. Clinical Infectious Diseases, 52, e162\u2013e193. https:\/\/doi.org\/10.1093\/cid\/cir257","DOI":"10.1093\/cid\/cir257"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Schiffer, C.A., Mangu, P.B., Wade, J.C., Camp-Sorrell, D., Cope, D.G., El-Rayes, B.F., . . . Levine, M. (2013). Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 31, 1357\u20131370. https:\/\/doi.org\/10.1200\/JCO.2012.45.5733","DOI":"10.1200\/JCO.2012.45.5733"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Stephens, L.C., Haire, W.D., Tarantolo, S., Reed, E., Schmit-Pokorny, K., Kessinger, A., & Klein, R. (1997). Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC). Transfusion Science, 18, 187\u2013193.","DOI":"10.1016\/S0955-3886(97)00008-8"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/22\/2\/heparin-versus-normal-saline-flushing-effectiveness-managing-central-venous-catheters","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T17:18:00Z","timestamp":1521220680000},"score":1,"resource":{"primary":{"URL":"http:\/\/cjon.ons.org\/cjon\/22\/2\/heparin-versus-normal-saline-flushing-effectiveness-managing-central-venous-catheters"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1188\/18.cjon.199-202","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,1]]}}}